NOVEMBER 2022LIFE SCIENCES REVIEW6Biotechnology with its new products and technologies has always stayed as an important industry. With the outbreak of COVID-19, the biotechnology industry yet again proved to be crucial with its tireless efforts to fight the pandemic. The global biotechnology market is estimated to grow steadily with a CAGR of 8.7 per cent from 2022 to 2030.The main driver for this steady growth is the adoption of various technologies by the biotechnology industry such as AI, personalised medicine, ML, synthetic biology, and data analytics. These trends have helped the industry to streamline the processes, be prompt, and cost-effective. It has also opened up immense possibilities in drug research and discovery. When looking at the overall global market, Europe accounts for 20 per cent of it, making the EU one of the most important marketspace for biotechnology companies to launch new drugs. To enter this market biotechnology and pharmaceutical companies need regulatory approval from EMA and/or MHRA. As emerging biotech companies expand into Europe, they have several options to reach the market like go alone, partnership, or acquisition before commercialisation. In this edition of Life Sciences Review Europe, we present you with the list of top ten biotech startups in Europe and top 5 biotech startups in the UK market space which are at the front line of innovation in the region's biotechnology arena. This edition contains insights from Andrew Garrett, PhD, Executive Vice President, Scientific Operations, ICON Clinical Research. Quercis Pharma, Tetra Pharm Technologies, and Clinical Net, with its top-notch research and services, are opening doors to new possibilities in biotechnology. Life Sciences Review Europe also presents you with exclusive insights and thought pieces from expert CIOs and CXOs - Samir Ounzain, Scientist, regulatory RNAs, HAYA Therapeutics, Avina Sugiarto, Partner, East Ventures, and Emmanuel Hui, Principal, Pentepebble, discussing and providing their ideas on the trends currently practiced in the industry. We hope these valuable insights from industry leaders and solutions from leading solution providers featured in this edition will assist you in making informed decisions for your businesses. EDITORIALRevolutionising Biotechnology with Evolving TechnologiesCopyright © 2022 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com November - 04 - 2022, Vol 03, Issue - 06 Published by ValleyMedia, Inc. (ISSN 2831-8331)To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com Editorial StaffAaron PierceCarolynn WaltersGiftson JoshuaJoe Philip Shirley FaithRussell ThomasVisualizersRonald DonovanDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsVictor Cruz
< Page 5 | Page 7 >